Management of postpneumonectomy Aspergillus empyema extending into the thoracic wall: a plea for radical surgery and caution when using liposomal amphotericin B
Open Access
- 1 December 2003
- journal article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 2 (4) , 682-684
Abstract
Semi-invasive aspergillosis is a rare disease leading to severe complications even in fully immunocompetent patients. The therapeutic role of systemic and intrapleural antifungal agents remains not well known. We report herein the case of a 54-year-old woman who developed Aspergillus empyema invading the thoracic wall and subcutaneous tissues after completion pneumonectomy for aspergilloma. She initially was treated conservatively with systemic and intrapleural amphotericin B without any success and developed a severe anaphylactic reaction to intravenous liposomal amphotericin B (Ambisome®). She then underwent an open-window thoracotomy with intrathoracic transposition of a latissimus dorsi muscle flap and was started on itraconazole therapy. The thoracostomy was closed after 6 months and the patient is doing well without any signs of recurrent infection after 3 years.Keywords
This publication has 3 references indexed in Scilit:
- Chronic forms of pulmonary aspergillosisClinical Microbiology and Infection, 2001
- Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective studyInternational Journal of Infectious Diseases, 1999
- Bronchopulmonary and pleural aspergillosis.1971